We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
83 hedge funds and large institutions have $353M invested in Oric Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
87% more capital invested
Capital invested by funds: $189M → $353M (+$165M)
72% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 18
27.71% more ownership
Funds ownership: 73.28% → 100.99% (+28%)
25% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 20
19% more funds holding
Funds holding: 70 → 83 (+13)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
68% less call options, than puts
Call options by funds: $336K | Put options by funds: $1.03M
Holders
83
Holders Change
+13
Holders Change %
+18.57%
% of All Funds
1.3%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.11%
New
31
Increased
25
Reduced
20
Closed
18
Calls
$336K
Puts
$1.03M
Net Calls
-$699K
Net Calls Change
-$745K
Top Buyers
| 1 |
NI
Nextech Invest
Zurich,
Switzerland
|
+$24.3M |
| 2 |
VA
VR Adviser
New York
|
+$12.2M |
| 3 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$12.2M |
| 4 |
BlackRock
New York
|
+$10.7M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$6.91M |
Top Sellers
| 1 |
SCM
Suvretta Capital Management
New York
|
-$8.01M |
| 2 |
Millennium Management
New York
|
-$6.31M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.56M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.29M |
| 5 |
O
OrbiMed
New York
|
-$1.17M |
